Sumitomo Mitsui Trust Holdings, Inc. Natera, Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 740,837 shares of NTRA stock, worth $128 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
740,837
Previous 671,382
10.35%
Holding current value
$128 Million
Previous $85.3 Million
37.43%
% of portfolio
0.08%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding NTRA
# of Institutions
633Shares Held
123MCall Options Held
821KPut Options Held
1.01M-
Vanguard Group Inc Valley Forge, PA12.3MShares$2.14 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.17 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.74MShares$1.17 Billion0.12% of portfolio
-
Jpmorgan Chase & CO New York, NY6.7MShares$1.16 Billion0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.43MShares$768 Million3.74% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.8B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...